Chinese english Germany Japanese Korea

1-(2-((1R,3S)-2,2-DIMETHYL-3-(2-METHYL-1H-INDOL-3-YL)CYCLOPROPYL)-N-(4-(TRIFLUOROMETHYL)BENZYL)ACETAMIDO)-N-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTANECARBOXAMIDE

1-(2-((1R,3S)-2,2-DIMETHYL-3-(2-METHYL-1H-INDOL-3-YL)CYCLOPROPYL)-N-(4-(TRIFLUOROMETHYL)BENZYL)ACETAMIDO)-N-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTANECARBOXAMIDE Struktur
CAS-Nr.
Englisch Name:
1-(2-((1R,3S)-2,2-DIMETHYL-3-(2-METHYL-1H-INDOL-3-YL)CYCLOPROPYL)-N-(4-(TRIFLUOROMETHYL)BENZYL)ACETAMIDO)-N-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTANECARBOXAMIDE
Synonyma:
TOSLAB 802897;1-(2-((1R,3S)-2,2-DIMETHYL-3-(2-METHYL-1H-INDOL-3-YL)CYCLOPROPYL)-N-(4-(TRIFLUOROMETHYL)BENZYL)ACETAMIDO)-N-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTANECARBOXAMIDE
CBNumber:
CB8491596
Summenformel:
C38H43F3N4O2
Molgewicht:
644.77
MOL-Datei:
Mol file
Request For Quotation

1-(2-((1R,3S)-2,2-DIMETHYL-3-(2-METHYL-1H-INDOL-3-YL)CYCLOPROPYL)-N-(4-(TRIFLUOROMETHYL)BENZYL)ACETAMIDO)-N-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTANECARBOXAMIDE Eigenschaften

Sicherheit

1-(2-((1R,3S)-2,2-DIMETHYL-3-(2-METHYL-1H-INDOL-3-YL)CYCLOPROPYL)-N-(4-(TRIFLUOROMETHYL)BENZYL)ACETAMIDO)-N-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTANECARBOXAMIDE Chemische Eigenschaften,Einsatz,Produktion Methoden

1-(2-((1R,3S)-2,2-DIMETHYL-3-(2-METHYL-1H-INDOL-3-YL)CYCLOPROPYL)-N-(4-(TRIFLUOROMETHYL)BENZYL)ACETAMIDO)-N-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTANECARBOXAMIDE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-(2-((1R,3S)-2,2-DIMETHYL-3-(2-METHYL-1H-INDOL-3-YL)CYCLOPROPYL)-N-(4-(TRIFLUOROMETHYL)BENZYL)ACETAMIDO)-N-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTANECARBOXAMIDE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Technology for Organic Synthesis Laboratory TOSLab --
 Russia 6064 69
  • TOSLAB 802897
  • 1-(2-((1R,3S)-2,2-DIMETHYL-3-(2-METHYL-1H-INDOL-3-YL)CYCLOPROPYL)-N-(4-(TRIFLUOROMETHYL)BENZYL)ACETAMIDO)-N-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTANECARBOXAMIDE
Copyright 2019 © ChemicalBook. All rights reserved